# Codex Review: medical_monitoring_p9_evidence_order_20260805

Date: 2026-08-05
Execution mode: Codex direct; no external agent, service, provider, browser, or real-project activation.
Delegated-agent output: not used; runner reservation retained only as workflow bookkeeping.
Hermes boundary: the reserved Hermes role was not dispatched; its allowed scope would have been planning only, not final acceptance.

## Verdict

**Pass for this bounded source/UI slice; not a release or runtime acceptance.**

## Boundary Check

- Source changes are limited to `frontend/src/App.jsx`, `frontend/src/styles.css`, the verified generated `frontend/dist/` bundle, and this task's context/record/review/metrics files.
- No backend, database, production project source, runtime state, provider, service, port, browser, or external-agent execution was activated.
- The formal real-loop gate remains `read_only / blocked`; 8911/5174/8910/4173 remain empty.

## Codex Verification

- `node --test frontend/src/features/medical-monitoring/*.test.mjs`: **33/33 test files passed, 0 failed**.
- `npm run build` in `frontend/`: **1953 modules transformed, build passed**; existing >500 kB bundle advisory remains.
- Source review confirms the rendered sequence is explicit and fixed: `1 原始事实 → 2 方案依据 → 3 系统规则 / 计算 → 4 来源定位`; missing stages remain visible and do not substitute the risk title as a fact.
- A bounded static contract check confirmed the four labels occur in that order and both locator disclosure elements are present.
- Locator text is now inside keyboard-accessible `<details>` disclosures; the existing read-only source action and project-identity guards are unchanged.
- Browser/visual acceptance was intentionally not run because the formal gate blocks runtime activation; this remains unverified.

## Delegated-Agent Output Review

- No delegated output was used. Codex inspected the PRD gap, current frontend, evidence contracts, and source-fragment API directly.
- No backend evidence semantics were changed, so frozen snapshot authority and source locator binding remain out of scope and unchanged.

## Residual Risk

- Actual desktop rendering, keyboard navigation in the live app, and real-project evidence density remain unverified until formal reviewer outcomes reopen the runtime gate.
- The existing Vite large-bundle advisory remains unrelated to this slice.
